Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Targeting ferroptosis has emerged as a promising strategy for the prevention and treatment of NDDs
"We think this addresses and responds to repeated call(s) for lower list prices on the (Capitol) Hill and elsewhere, as well as the call for lower list prices from our patients who want access to these innovative medicines," Millar said
Accessible at: [Accessed 26th June 2025]
P., Vacante, M., Colonna, V., & Motta, M
Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: Post-hoc analysis of an open-label, randomised, phase 3 trial
US$ 29.29
%25201.png)
US$ 23.21
US$ 23.65
US$ 24.59
